| 000 | 00726namaa22001934a#4500 | ||
|---|---|---|---|
| 001 | 021566 | ||
| 008 | 130822s2000 xxc f 1 eng d | ||
| 020 | _a1-895561-89-2 | ||
| 082 |
_a617.356 _bT258d2 _811 |
||
| 245 |
_aTechnology report : _bdrug treatments for alzheimer's disease III. A review of published pharmacoeconomic evaluations / _cVijay K. Shukla, B., Nicolaass Otten, Doug Coyle |
||
| 260 |
_aOttawa, Can. : _bCCOHTA, _c2000. |
||
| 300 | _a37 p. | ||
| 490 |
_aTechnology report ; _n11 |
||
| 650 |
_aEnfermedad de Alzheimer _xDiagnóstico _xEconomÃa. |
||
| 700 |
_aCoyle, Doug _ecoaut. |
||
| 700 |
_aOtten, Nicolaas _ecoaut. |
||
| 710 | _aCanadian Coordinating Office for Health Technology Assessment | ||
| 942 | _cBK | ||
| 999 |
_c9982 _d9982 |
||